The FDA has posted a transcript of the controversial February 3 meeting of the Cardiovascular and Renal Advisory Committee, along with minutes and revised briefing documents.

Here is a chronology of coverage of this hearing by CardioBrief and others.

You can download the transcript here.

You can download the minutes here.

You can access the FDA’s revised briefing document and errata, as well as Lilly’s briefing document, here.